Processa Pharmaceuticals, Inc. SEC filings PCSA
Processa Pharmaceuticals, Inc. has 705 filings in SEC EDGAR's recent list, going back to Oct 28, 2011. Its latest annual report, Form 10-K, was filed on Mar 18, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Nov 5, 2026 | — |
| DEFA14A | Additional proxy material | Nov 5, 2026 | — |
| 8-K |
Current report
Other events
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Nov 4, 2026 | Nov 2, 2026 |
| 8-K |
Current report
Other events
|
Oct 29, 2026 | Oct 27, 2026 |
| EFFECT | Filing | Oct 23, 2026 | — |
| DEF 14A | Proxy statement | Oct 22, 2026 | Nov 30, 2026 |
| PRE 14A | Preliminary proxy statement | Oct 9, 2026 | Oct 9, 2026 |
| PRE 14A | Preliminary proxy statement | Oct 9, 2026 | Oct 9, 2026 |
| S-3 | Shelf registration | Oct 9, 2026 | — |
| 8-K/A |
Amended current report
Other events
|
Oct 5, 2026 | Jul 23, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 18, 2026 | — |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Aug 11, 2026 | Aug 8, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Aug 4, 2026 | Jul 30, 2026 |
| 4 | Insider transaction | Jul 30, 2026 | Jul 28, 2026 |
| 3 | Initial insider ownership | Jul 30, 2026 | Jul 28, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Jul 29, 2026 | Jul 23, 2026 |
| 4 | Insider transaction | Jul 28, 2026 | Jul 26, 2026 |
| 4 | Insider transaction | Jul 28, 2026 | Jul 26, 2026 |
| 4 | Insider transaction | Jul 28, 2026 | Jul 26, 2026 |
| 4 | Insider transaction | Jul 28, 2026 | Jul 26, 2026 |
| 4 | Insider transaction | Jul 28, 2026 | Jul 26, 2026 |
| 4 | Insider transaction | Jul 28, 2026 | Jul 26, 2026 |
| 4 | Insider transaction | Jul 28, 2026 | Jul 26, 2026 |
| 4 | Insider transaction | Jul 28, 2026 | Jul 26, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 26, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 26, 2026 |
| DEF 14A | Proxy statement | Jun 18, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 1, 2026 | May 29, 2026 |
| 4 | Insider transaction | Jun 1, 2026 | May 29, 2026 |
| 4 | Insider transaction | Jun 1, 2026 | May 29, 2026 |
| 4 | Insider transaction | Jun 1, 2026 | May 29, 2026 |
| 4 | Insider transaction | Jun 1, 2026 | May 29, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 15, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 15, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 15, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 15, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 15, 2026 |
| 4/A | Form 4/a | May 19, 2026 | Apr 15, 2026 |
| 4/A | Form 4/a | May 19, 2026 | Apr 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | May 1, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | May 1, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | May 1, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | May 1, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | May 1, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | May 1, 2026 | Apr 30, 2026 |
| 10-K/A | Amended annual report | Apr 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 30, 2026 | Apr 30, 2026 |
| 4/A | Form 4/a | Apr 30, 2026 | Apr 15, 2026 |
| 4/A | Form 4/a | Apr 30, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 17, 2026 | Apr 15, 2026 |
| 4 | Insider transaction | Apr 17, 2026 | Apr 15, 2026 |
| 4 | Insider transaction | Apr 17, 2026 | Apr 15, 2026 |
| 4 | Insider transaction | Apr 17, 2026 | Apr 15, 2026 |
| 4 | Insider transaction | Apr 17, 2026 | Apr 15, 2026 |
| 4 | Insider transaction | Apr 17, 2026 | Apr 15, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 31, 2026 |
| 10-K | Annual report | Mar 18, 2026 | Dec 31, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 23, 2026 | — |
| 8-K |
Current report
Agreement ended
|
Feb 19, 2026 | Feb 12, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| 4 | Insider transaction | Feb 4, 2026 | Jan 1, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Jan 1, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Jan 1, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Jan 1, 2026 |
| 8-K |
Current report
Other events
|
Jan 7, 2026 | Jan 6, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Dec 15, 2025 | Dec 12, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 7, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 15, 2025 | — |
| 4 | Insider transaction | Oct 3, 2025 | Oct 1, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Oct 1, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Oct 1, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Oct 1, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Oct 1, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Oct 1, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Oct 1, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Oct 1, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Oct 1, 2025 |
| 4 | Insider transaction | Oct 3, 2025 | Oct 1, 2025 |
| S-8 | Employee stock plan registration | Sep 22, 2025 | — |
| 4/A | Filing | Sep 18, 2025 | Jul 24, 2025 |
| 4/A | Filing | Sep 18, 2025 | Jul 24, 2025 |
| 4/A | Filing | Sep 18, 2025 | Jul 24, 2025 |
| 4/A | Filing | Sep 18, 2025 | Jul 24, 2025 |
| 4/A | Filing | Sep 18, 2025 | Jul 24, 2025 |
| 4/A | Filing | Sep 18, 2025 | Jul 24, 2025 |
| 4/A | Filing | Sep 18, 2025 | Jul 24, 2025 |
| 4/A | Filing | Sep 18, 2025 | Jul 24, 2025 |
| 4/A | Filing | Sep 18, 2025 | Jul 24, 2025 |
| 4/A | Filing | Sep 18, 2025 | Jul 24, 2025 |
| 8-K/A |
Amended current report
Bylaw or fiscal year change, Shareholder vote results
|
Sep 16, 2025 | Sep 11, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Sep 12, 2025 | Sep 11, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Sep 10, 2025 | Sep 10, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Sep 2, 2025 | Sep 2, 2025 |
| DEFA14A | Additional proxy material | Aug 25, 2025 | — |
| 8-K |
Current report
Other events
|
Aug 25, 2025 | Aug 25, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 8-K/A |
Amended current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Aug 14, 2025 | Aug 4, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | Aug 13, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 13, 2025 | — |
| DEF 14A | Proxy statement | Aug 13, 2025 | Aug 13, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 12, 2025 | — |
| 8-K |
Current report
Listing notice
|
Aug 8, 2025 | Aug 7, 2025 |
| CORRESP | Letter to the SEC | Aug 8, 2025 | — |
| PRER14A | Filing | Aug 8, 2025 | — |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Aug 7, 2025 | Aug 4, 2025 |
| UPLOAD | Letter from the SEC | Aug 6, 2025 | — |
| PRE 14A | Preliminary proxy statement | Jul 31, 2025 | Jul 31, 2025 |
| 4 | Insider transaction | Jul 28, 2025 | Jul 28, 2025 |
| 4 | Insider transaction | Jul 28, 2025 | Jul 24, 2025 |
| 4 | Insider transaction | Jul 28, 2025 | Jul 24, 2025 |
| 4 | Insider transaction | Jul 28, 2025 | Jul 24, 2025 |
| 4 | Insider transaction | Jul 28, 2025 | Jul 24, 2025 |
| 4 | Insider transaction | Jul 28, 2025 | Jul 24, 2025 |
| 4 | Insider transaction | Jul 28, 2025 | Jul 24, 2025 |
| 4 | Insider transaction | Jul 28, 2025 | Jul 24, 2025 |
| 4 | Insider transaction | Jul 28, 2025 | Jul 24, 2025 |
| 4 | Insider transaction | Jul 28, 2025 | Jul 24, 2025 |
| 8-K |
Current report
Other events
|
Jul 25, 2025 | Jul 25, 2025 |
| 424B5 | Prospectus supplement | Jul 25, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Jul 18, 2025 | Jul 18, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jul 15, 2025 | Jul 15, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 1, 2025 | Jun 27, 2025 |
| 8-K |
Current report
Material agreement, Shareholder vote results
|
Jun 30, 2025 | Jun 24, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 24, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 23, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 23, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 18, 2025 | Jun 17, 2025 |
| 424B4 | Prospectus | Jun 18, 2025 | — |
| EFFECT | Filing | Jun 17, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 17, 2025 | Jun 17, 2025 |
| CORRESP | Letter to the SEC | Jun 13, 2025 | — |
| CORRESP | Letter to the SEC | Jun 13, 2025 | — |
| S-1 | Registration statement | Jun 13, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2025 | — |
| DEF 14A | Proxy statement | May 12, 2025 | May 12, 2025 |
| DEFA14A | Additional proxy material | May 12, 2025 | — |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| UPLOAD | Letter from the SEC | May 7, 2025 | — |
| PRE 14A | Preliminary proxy statement | May 1, 2025 | May 1, 2025 |
| DRSLTR | Filing | May 1, 2025 | — |
| DRS | Filing | May 1, 2025 | — |
| 4 | Insider transaction | Apr 11, 2025 | Apr 1, 2025 |
| 4 | Insider transaction | Apr 11, 2025 | Apr 1, 2025 |
| 4 | Insider transaction | Apr 11, 2025 | Apr 11, 2025 |
| 4 | Insider transaction | Apr 11, 2025 | Apr 1, 2025 |
| 10-K | Annual report | Mar 20, 2025 | Dec 31, 2024 |
| 4/A | Filing | Feb 18, 2025 | Jan 27, 2025 |
| 4/A | Filing | Feb 18, 2025 | Jan 27, 2025 |
| 4/A | Filing | Feb 18, 2025 | Feb 17, 2025 |
| 4/A | Filing | Feb 18, 2025 | Jan 27, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 11, 2025 | Feb 11, 2025 |
| 8-K |
Current report
Listing notice
|
Feb 10, 2025 | Feb 4, 2025 |
| 4 | Insider transaction | Jan 31, 2025 | Jan 27, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 30, 2025 | Jan 27, 2025 |
| 4 | Insider transaction | Jan 29, 2025 | Jan 27, 2025 |
| 4 | Insider transaction | Jan 29, 2025 | Jan 27, 2025 |
| 4 | Insider transaction | Jan 29, 2025 | Jan 27, 2025 |
| 424B4 | Prospectus | Jan 29, 2025 | — |
| EFFECT | Filing | Jan 27, 2025 | — |
| CORRESP | Letter to the SEC | Jan 27, 2025 | — |
| CORRESP | Letter to the SEC | Jan 27, 2025 | — |
| S-1/A | Amended registration statement | Jan 27, 2025 | — |
| CORRESP | Letter to the SEC | Jan 23, 2025 | — |
| CORRESP | Letter to the SEC | Jan 23, 2025 | — |
| CORRESP | Letter to the SEC | Jan 17, 2025 | — |
| CORRESP | Letter to the SEC | Jan 17, 2025 | — |
| S-1/A | Amended registration statement | Jan 16, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 30, 2024 | — |
| S-1 | Registration statement | Dec 20, 2024 | — |
| 8-K |
Current report
Auditor change
|
Nov 6, 2024 | Oct 31, 2024 |
| 10-Q | Quarterly report | Oct 30, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Other events
|
Oct 2, 2024 | Oct 2, 2024 |
| 4 | Insider transaction | Sep 18, 2024 | Sep 3, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PCSA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Vero Beach, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1533743
- Former names
- Heatwurx, Inc. (until Oct 20, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.